Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: STE

STERIS plc

Healthcare | Medical - Devices
$224.15 -2.68 (-1.18%) as of 2026-09-04 18:21 UTC
Market Cap$21.9B
Volume107.6K
EPS (TTM)$7.93

STERIS plc (NYSE: STE) is a $21.9B medical - devices company trading at $224.15 (−1.2% today) — 28.3× trailing earnings, yielding 1.09%. Figures from SEC EDGAR and market feeds; updated 2026-09-04 18:21 UTC.

52-Week Range
Low $198.01High $241.39

What STERIS plc does

STERIS is a global provider of products and services focused on infection prevention for healthcare, medical device, and pharmaceutical customers. The company operates through three segments: Healthcare, which serves sterile processing departments and procedural centers with consumables, equipment, and repair services; Applied Sterilization Technologies, which provides contract sterilization and laboratory testing services to medical device and pharmaceutical manufacturers; and Life Sciences, which supplies products and services for biopharmaceutical and medical device manufacturing facilities…

Summarized from STERIS plc’s SEC filings · Read the filing ↗

Key facts

Quote
Price$224.15
Change (1D)-2.68 (-1.18%)
Market cap$21.9B
Volume107.6K shares
52-week range$198.01 – $241.39
Valuation
P/E (TTM)28.27×
EV/EBITDA14.70×
EPS (TTM)$7.93
Dividend yield1.09%
Price/book3.05×
Return on equity10.89%
Debt/equity0.27
Returns
52-week return+13.2%

Revenue, margins & earnings

FY2022 Net income: $244MFY2022 Taxes & interest: $234MFY2022 Operating expenses: $1.41BFY2022 Cost of revenue: $2.34B$4.22BFY2022FY2023 Net income: $107MFY2023 Taxes & interest: $684MFY2023 Operating expenses: $1.19BFY2023 Cost of revenue: $2.56B$4.54BFY2023FY2024 Net income: $378MFY2024 Taxes & interest: $458MFY2024 Operating expenses: $1.38BFY2024 Cost of revenue: $2.92B$5.14BFY2024FY2025 Net income: $615MFY2025 Taxes & interest: $252MFY2025 Operating expenses: $1.54BFY2025 Cost of revenue: $3.06B$5.46BFY2025FY2026 Net income: $782MFY2026 Taxes & interest: $320MFY2026 Operating expenses: $1.52BFY2026 Cost of revenue: $3.31B$5.94BFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-12
  • 2026-08-12Sohi MohsenM4,058$349.9K
  • 2026-08-12Sohi MohsenSELL-4,058$956.8K
  • 2026-08-12Sohi MohsenA1,099—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does STERIS plc do?

STERIS is a global provider of products and services focused on infection prevention for healthcare, medical device, and pharmaceutical customers.

What is STE's valuation?

STE trades at $224.15, 28.27× trailing earnings, 14.70× EV/EBITDA, as of 2026-09-04. It carries a 1.09% dividend yield.

When did STE last file with the SEC?

STERIS plc's most recent SEC filing on record is a DEF 14A filed 2026-06-11. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-04 18:21 UTC. This page is also available as JSON at /api/data?ticker=STE and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for STE and 5,000+ tickers.

Create a free account — keep STE
For your agent
GET /api/data?ticker=STE

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt